Take part in a vaccine in pregnancy study
The University of Otago is currently recruiting pregnant women for a clinical trial of a new RSV (respiratory syncytial virus) immunisation - in collaboration with Christchurch Women’s Hospital.
RSV is the virus that causes bronchiolitis in babies and infants, often leading to hospital admission. By the age of two, almost all children have been exposed to RSV. RSV illness early in life may also increase the chances of a child developing wheezing and asthma when they are older.
The RSV vaccine is given to pregnant women during the third trimester to protect their babies from severe RSV infection.
This trial is a multinational study that will determine the efficacy of the vaccine for protecting babies against RSV. Christchurch is one of six New Zealand sites taking part in this global trial, now coming into its second year of recruitment.
The researchers are looking for interested eligible pregnant women to join the study, until mid-June 2017. Potential participants will need to be:
- due to give birth between 20 March and 11 July 2017
- aged between 18 and 40 years old
- in good general physical health
- having a singleton pregnancy (e.g. not a multiple birth such as twins).
Contact Research Midwife Di Leishman to arrange a meeting if you are interested in participating, or know someone who is (di.leishman[at]otago.ac.nz or 364 4631). You can also contact Di if you have any questions or want to discuss the vaccine trial in more detail.